Back to VA VANGUARD CAPITAL MANAGEMENT LLC
LXEO2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in LEXEO THERAPEUTICS INC
Yes. Vanguard Capital Management holds 3,125,893 shares of LXEO (Lexeo Therapeutics), worth $14.6M, as of its Q2 2026 13F filing. It increased the position by 118,800 shares (+4.0%) from Q1 2026. Vanguard Capital Management has held LXEO in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$14.6M
Current Shares
3.1M
Total Value Change
-$2.7M
Total Shares Change
+118,800
Quarter-by-Quarter History
Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.